首页> 外文期刊>科儀新知 >NMR Structural Genomics of Klebsiella Pneumoniae
【24h】

NMR Structural Genomics of Klebsiella Pneumoniae

机译:肺炎克雷伯菌的NMR结构基因组学

获取原文
获取原文并翻译 | 示例
           

摘要

Based on the statistical analysis by the Department of Health, pneumonia is one of the top ten cases causing death every year in Taiwan. Klebsiella pneumoniae (KP) is one of the top five pathogenic bacteria that cause community and hospital infection of pneumonia in Taiwan. In some immuno-deficient patients such as diabetic, KP forms opportunistic infection and causes septicemia combining with Pyogenic liver abscess. It is estimated that ~10% of these patients accompany meningitis and metastatic ophthalmitis. Recently, on the basis of the epidemiological investigations, the drug-resistant mutant genes of KP have been found due to the misuse of antibiotics, and even evolve into new strains which make lots of difficulties on therapies. It is therefore that the National Research Programs for Genomic Medicine (NRPGM) lists KP as one of the major bacterial researches that should be pursued. Our laboratory, a member of the KP functional and structural genomics projects of Academia Sinica, has selected several target proteins related to virulence and drug-resistance factors, as discovered by Dr. Shin-Feng Tsai in NHRI, for structural study. A variety of biophysical techniques, especially high-resolution NMR experiments, will be carried out on these target proteins. It is hoped that the 3D solution structures of these target proteins as well as other biophysical properties could provide valuable information for drug development on therapeutics related to Klebsiella pneumoniae.
机译:根据卫生署的统计分析,肺炎是台湾每年造成死亡的十大病例之一。肺炎克雷伯菌是台湾地区导致社区和医院感染肺炎的五种致病细菌之一。在某些免疫缺陷的患者(例如糖尿病患者)中,KP形成机会感染,并导致败血症和化脓性肝脓肿。据估计,这些患者中约有10%伴有脑膜炎和转移性眼炎。近来,在流行病学调查的基础上,由于滥用抗生素,发现了KP的耐药突变基因,甚至进化成新的菌株,给治疗带来很大困难。因此,国家基因组医学研究计划(NRPGM)将KP列为应进行的主要细菌研究之一。我们的实验室是中国科学院KP功能和结构基因组计划的成员,已经选择了几种与毒力和耐药性因子相关的靶蛋白,这些蛋白是由NHRI的Shin Shin-Feng Tsai博士发现的,用于结构研究。将对这些靶蛋白进行多种生物物理技术,尤其是高分辨率NMR实验。希望这些靶蛋白的3D溶液结构以及其他生物物理特性可以为与肺炎克雷伯菌相关的药物开发提供有价值的信息。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号